Home›Companies›Healthcare›Hyperion Surgical

Hyperion Surgical, Inc.

Develops robotic IV placement technology for clinicians treating patients with difficult vein access.

Updated Nov 10, 2026·Latest SEC filing Jul 8, 2026·Suggest an edit

About Hyperion Surgical

Hyperion Surgical is a private company based in Weston, Florida. It has reported $19,183,232 raised in two offerings on Form D since November 2023. Its chief executive is Eric Peterson, M.d..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 18, 2026Jul 8, 2026$13,164,921of $23.7M target42$313KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Nov 3, 2023Nov 20, 2023$6,018,311of $9.0M target48$125KEquityRule 506(b)Form D ↗
Total, two offerings$19,183,232

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Hyperion Surgical's Form D filed Jul 8, 2026.

ED
Eric Peterson, M.d.
Co-Founder and CEO, director
AR

Sources

  1. SECHyperion Surgical, Inc. filing history
  2. CompanyContact
  3. CompanyFirst-in-human study announcement